GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (FRA:BVF) » Definitions » Cyclically Adjusted Price-to-FCF

Bausch Health (FRA:BVF) Cyclically Adjusted Price-to-FCF : 1.88 (As of May. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Bausch Health Cyclically Adjusted Price-to-FCF?

As of today (2024-05-14), Bausch Health's current share price is €6.65. Bausch Health's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €3.53. Bausch Health's Cyclically Adjusted Price-to-FCF for today is 1.88.

The historical rank and industry rank for Bausch Health's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:BVF' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 1.07   Med: 6.86   Max: 118.91
Current: 1.89

During the past years, Bausch Health's highest Cyclically Adjusted Price-to-FCF was 118.91. The lowest was 1.07. And the median was 6.86.

FRA:BVF's Cyclically Adjusted Price-to-FCF is ranked better than
98.78% of 329 companies
in the Drug Manufacturers industry
Industry Median: 33.59 vs FRA:BVF: 1.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bausch Health's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €0.321. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €3.53 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted Price-to-FCF Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.50 5.53 6.49 1.65 2.01

Bausch Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.12 2.04 2.13 2.01 2.78

Competitive Comparison of Bausch Health's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted Price-to-FCF falls into.



Bausch Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bausch Health's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=6.65/3.53
=1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bausch Health's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.321/125.4675*125.4675
=0.321

Current CPI (Mar. 2024) = 125.4675.

Bausch Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.544 99.473 0.686
201409 1.148 99.394 1.449
201412 1.611 98.367 2.055
201503 1.013 99.789 1.274
201506 0.917 100.500 1.145
201509 1.740 100.421 2.174
201512 1.360 99.947 1.707
201603 1.271 101.054 1.578
201606 0.978 102.002 1.203
201609 1.221 101.765 1.505
201612 1.220 101.449 1.509
201703 2.094 102.634 2.560
201706 0.562 103.029 0.684
201709 1.053 103.345 1.278
201712 1.211 103.345 1.470
201803 0.904 105.004 1.080
201806 0.319 105.557 0.379
201809 1.192 105.636 1.416
201812 0.637 105.399 0.758
201903 0.922 106.979 1.081
201906 0.694 107.690 0.809
201909 1.113 107.611 1.298
201912 0.380 107.769 0.442
202003 0.484 107.927 0.563
202006 0.322 108.401 0.373
202009 0.413 108.164 0.479
202012 0.716 108.559 0.828
202103 0.883 110.298 1.004
202106 0.915 111.720 1.028
202109 1.317 112.905 1.464
202112 0.059 113.774 0.065
202203 -0.302 117.646 -0.322
202206 0.175 120.806 0.182
202209 -3.674 120.648 -3.821
202212 0.987 120.964 1.024
202303 0.265 122.702 0.271
202306 0.440 124.203 0.444
202309 0.605 125.230 0.606
202312 0.616 125.468 0.616
202403 0.321 125.468 0.321

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (FRA:BVF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bausch Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (FRA:BVF) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (FRA:BVF) Headlines

No Headlines